---
document_datetime: 2025-02-05 09:44:38
document_pages: 24
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/nivestim-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: nivestim-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 13.4467649
conversion_datetime: 2025-12-27 17:13:19.24588
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Nivestim

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0085               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 04/02/2025                          |                                             | PL                               |           |
| IB/0083              | B.II.e.z - Change in container closure system of the Finished Product - Other variation          | 31/10/2024                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0082/G   | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                             | 29/10/2024   | n/a   |             |           |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-------------|-----------|
| IB/0080     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by                                                                                                                                                                                                           | 15/10/2024   |       | SmPC and PL | the MAH   |
| IB/0081     | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                     | 07/10/2024   | n/a   |             |           |
|             | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 11/07/2024   | n/a   |             | IA/0078/G |
| IA/0077     | A.6 - Administrative change - Change in ATC Code/ATC Vet Code                                                                                                                                                                                                                                                                                                                                                                                                  | 08/04/2024   |       | SmPC        |           |

<div style=\"page-break-after: always\"></div>

| IB/0076   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 23/02/2024   |     | SmPC   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-----|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0074/G | This was an application for a group of variations. Grouped application consisting of: C.I.13: Submission of the final report from the non- interventional (NI) post authorization safety study (PASS) study ZOB-NIV-1513/C1121008, listed as a category 3 study in the RMP. This is a multinational, multi-centre, prospective, non-interventional, post- authorisation safety study in Healthy Donors (HDs) exposed to nivestim (biosimilar filgrastim) for Haematopoietic Stem Cell (HSC) Mobilisation (NEST). The RMP version 12.2 has also been submitted. C.I.11: Submission of an updated RMP version 12.2 to remove the important potential risk of cytogenetic abnormalities and development of secondary haematologic malignancies from the list of safety concerns following completion of the category 3 NI PASS study ZOB-NIV-1513/C1121008. The requested group of variations proposed amendments to the Risk Management Plan (RMP). C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission | 11/01/2024   | n/a |        | This variation concerns the final study reports of the post- authorization safety study ZOB-NIV-1513/C1121008, listed as a category 3 study in the Risk Management Plan (RMP), to evaluate long-term safety of Nivestim in healthy donors. Overall, no new safety concerns were observed and were consistent with the known safety profiles of the biosimilar Nivestim and Neupogen reference product. The RMP is updated accordingly (version 12.2) to move reference of study ZOB-NIV-1513 to a completed additional pharmacovigilance study. Additionally, the important potential risk of cytogenetic abnormalities and development of secondary haematologic malignancies were removed from the RMP list of safety concerns since no additional risk minimisation measures nor additional pharmacovigilance activities are proposed. |

<div style=\"page-break-after: always\"></div>

|           | - Changes (Safety/Efficacy) of Human and Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                             |            |            |                        | C.I.z Veterinary   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------|
| IB/0073/G | This was an application for a group of variations. B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                         | 09/06/2023 | n/a        |                        |                    |
| IB/0072   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                            | 22/05/2023 | 05/01/2024 | PL                     |                    |
| IB/0071   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                              | 12/01/2023 | 05/01/2024 | SmPC, Labelling and PL |                    |
| II/0070/G | This was an application for a group of variations. B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB B.I.a.1.j - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Replacement or addition of a site where batch control/testing takes place and any of the test method at the site is a biol/immunol method | 15/12/2022 | n/a        |                        |                    |

<div style=\"page-break-after: always\"></div>

|                    | B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                    |            |            |    |                                   |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|-----------------------------------|
| N/0069             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 22/09/2022 | 05/01/2024 | PL |                                   |
| IB/0068            | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                   | 15/09/2022 | n/a        |    |                                   |
| PSUSA/1391/ 202109 | Periodic Safety Update EU Single assessment - filgrastim                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 05/05/2022 | n/a        |    | PRAC Recommendation - maintenance |
| IB/0067/G          | This was an application for a group of variations. B.II.f.1.e - Stability of FP - Change to an approved stability protocol B.II.f.1.e - Stability of FP - Change to an approved stability protocol B.I.d.1.c - Stability of AS - Change in the re-test period/storage period or storage conditions - Change to an approved stability protocol B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor | 05/04/2022 | n/a        |    |                                   |

<div style=\"page-break-after: always\"></div>

|           | to an approved test procedure - Stability of FP - Change to an approved protocol                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |            |    | changes B.II.f.1.e stability   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|--------------------------------|
| IA/0066/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of                                                                                                                                                             | 07/02/2022 | n/a        |    | manufacturing sites            |
| N/0064    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                            | 01/10/2021 | 05/01/2024 | PL |                                |
| II/0063   | Submission of an updated RMP version 10.1 in order to update the RMP in accordance with GVP Module V and the Guidance on the format of the RMP in the EU - in integrated format (Rev. 2.0.1) and to propose deletion of selected safety concerns listed as important identified risk, important potential risk and missing information. C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated | 30/09/2021 | n/a        |    |                                |

<div style=\"page-break-after: always\"></div>

|           | by new additional data to be submitted by the MAH where significant assessment is required                                                                                                                                                                                                                               |            |            |                                  |                                                                                                                                                                                       |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0062    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                         | 31/03/2021 | 05/01/2024 | PL                               |                                                                                                                                                                                       |
| II/0061   | Update of section 6.5 of the SmPC to add a statement on the content of a derivative of natural rubber latex in the needle cover formulation. Section 6 of the Package Leaflet was updated accordingly. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 23/04/2020 | 18/11/2020 | SmPC and PL                      | Each pre filled syringe is affixed with a needle closed by a needle cover that contains epoxyprene, a derivative of natural rubber latex which may come into contact with the needle. |
| II/0059   | B.I.e.2 - Introduction of a post approval change management protocol related to the AS                                                                                                                                                                                                                                   | 26/03/2020 | n/a        |                                  |                                                                                                                                                                                       |
| IB/0057   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                             | 10/12/2019 | 18/11/2020 | SmPC, Annex II, Labelling and PL |                                                                                                                                                                                       |
| IB/0058/G | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                          | 09/12/2019 | n/a        |                                  |                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

| B.II.d.1.a - Change in the and/or limits of the finished specification limits B.II.d.1.c - Change in the and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.d - Change in the and/or limits of the finished non-significant specification B.II.d.1.d - Change in the and/or limits of the finished non-significant specification B.II.d.1.d - Change in the and/or limits of the finished non-significant specification B.II.d.1.d - Change in the and/or limits of the finished non-significant specification B.II.d.1.d - Change in the and/or limits of the finished non-significant specification B.II.d.1.z - Change in the and/or limits of the finished B.II.d.2.d - Change in test product - Other changes (including replacement B.II.d.2.d - Change in test product - Other changes (including replacement Change in test   | B.II.d.2.e -   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------|

<div style=\"page-break-after: always\"></div>

|                    | with the updated general monograph in the Ph. Eur.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |            |    |                                   |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|-----------------------------------|
| N/0060             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 02/12/2019 | 18/11/2020 | PL |                                   |
| PSUSA/1391/ 201809 | Periodic Safety Update EU Single assessment - filgrastim                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 16/05/2019 | n/a        |    | PRAC Recommendation - maintenance |
| IA/0056/G          | This was an application for a group of variations. B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished | 02/05/2019 | n/a        |    |                                   |

<div style=\"page-break-after: always\"></div>

|           | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.e.3.a - Change in test procedure for the immediate packaging of the finished product - Minor changes to an approved test procedure   |            |            |                        | procedure   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------|
| N/0055    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                 | 12/04/2019 | 16/09/2019 | PL                     |             |
| IB/0053   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                     | 13/11/2018 | 16/09/2019 | SmPC, Labelling and PL |             |
| IA/0052/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                | 07/09/2018 | 16/09/2019 | Annex II and PL        |             |

<div style=\"page-break-after: always\"></div>

|         | immediate packaging of the AS - Other variation B.I.c.2.b - Change in the specification parameters and/or limits of the immediate packaging of the AS - Addition of a new specification parameter to the specification with its corresponding test method B.I.c.2.c - Change in the specification parameters and/or limits of the immediate packaging of the AS - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter)   |            |            |                        | B.I.c.1.z - Change in   |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------|
| T/0051  | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                | 06/08/2018 | 23/08/2018 | SmPC, Labelling and PL |                         |
| IB/0050 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                     | 22/05/2018 | 23/08/2018 | SmPC and PL            |                         |
| IB/0049 | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                          | 24/10/2017 | 23/08/2018 | SmPC and PL            |                         |
|         | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                             | 20/07/2017 | 18/09/2017 | Annex II and PL        | IAIN/0048               |
| N/0047  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                   | 16/02/2017 | 18/09/2017 | Labelling and PL       |                         |
| IB/0046 | C.I.2.a - Change in the SPC, Labelling or PL of a                                                                                                                                                                                                                                                                                                                                                                                                                  | 11/10/2016 | 18/09/2017 | SmPC and PL            |                         |

<div style=\"page-break-after: always\"></div>

|           | generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                     |            |     |              |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------|
| IB/0045   | B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a                                                                                                                                                                                                                                                                                                                                                                       | 22/09/2016 | n/a | Member State |
| IB/0044   | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 01/08/2016 | n/a |              |
| IB/0043/G | This was an application for a group of variations. B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits | 20/06/2016 | n/a |              |

<div style=\"page-break-after: always\"></div>

| N/0042             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                    | 17/06/2016   | 06/07/2016   | PL   |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------|-----------------------------------|
| IG/0693            | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                  | 02/06/2016   | n/a          |      |                                   |
| PSUSA/1391/ 201509 | Periodic Safety Update EU Single assessment - filgrastim                                                                                                                                            | 13/05/2016   | n/a          |      | PRAC Recommendation - maintenance |
| IB/0040            | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                 | 29/02/2016   | n/a          |      |                                   |
| IB/0038            | B.I.d.1.c - Stability of AS - Change in the re-test period/storage period or storage conditions - Change to an approved stability protocol                                                          | 07/01/2016   | n/a          |      |                                   |
| IB/0036            | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                          | 22/12/2015   | n/a          |      |                                   |
| IG/0645            | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                     | 17/12/2015   | n/a          |      |                                   |
| II/0033            | C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated | 24/09/2015   | n/a          |      |                                   |

<div style=\"page-break-after: always\"></div>

|             | by new additional data to be submitted by the MAH where significant assessment is required                                                                                                                                                                                                                                                                                                                |            |            |                        |                            |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------|
| IAIN/0035/G | This was an application for a group of variations. B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within | 14/08/2015 | 06/07/2016 | SmPC, Labelling and PL | the range of the currently |
| IAIN/0034   | B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes                                                                                                                                                                                                        | 14/08/2015 | 06/07/2016 | SmPC, Labelling and PL |                            |
| IAIN/0032   | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                                | 16/07/2015 | 06/07/2016 | SmPC, Labelling and PL |                            |
| II/0029     | B.I.a.4.e - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of an in-process test which may have a significant effect on the overall quality of the AS                                                                                                                                                                                                           | 02/07/2015 | n/a        |                        |                            |
| II/0028/G   | This was an application for a group of variations. B.I.b.1.e - Change in the specification parameters and/or limits of an AS, starting                                                                                                                                                                                                                                                                    | 02/07/2015 | n/a        |                        |                            |

<div style=\"page-break-after: always\"></div>

|           | material/intermediate/reagent - Deletion of a specification parameter which may have a significant effect on the overall quality of the AS and/or the FP B.I.b.1.e - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a specification parameter which may have a significant effect on the overall quality of the AS and/or the FP   |            |            |                        |                                                                                                                                                                                                                                                                                                                                                            |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0025    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                 | 26/03/2015 | 27/05/2015 | SmPC, Labelling and PL | Based on the review of data on quality, safety and efficacy, including all variations introduced since the marketing authorisation was granted, the CHMP considered that the benefit-risk balance of Nivestim in the approved indications remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IG/0555   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                         | 22/05/2015 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                            |
| N/0027    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                        | 05/01/2015 | 27/05/2015 | PL                     |                                                                                                                                                                                                                                                                                                                                                            |
| IB/0026/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.2.a - Change in test procedure for AS or                                                                                                                                                                                      | 05/12/2014 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|           | changes to an approved test procedure B.III.2.a.1 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - AS                                                                                                                                 |            |            |                 |               |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|---------------|
| II/0022   | B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a                                                                                                                   | 25/09/2014 | n/a        |                 | biological AS |
| IG/0477   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                      | 03/09/2014 | n/a        |                 |               |
| IA/0023/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of | 01/08/2014 | 15/01/2015 | Annex II and PL |               |

<div style=\"page-break-after: always\"></div>

| IB/0021/G   | This was an application for a group of variations.                                                                                                                                                                                                           | 16/04/2014   | n/a        |             |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|
| IB/0019     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 21/01/2014   | 15/01/2015 | SmPC and PL |
| IG/0382     | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                              | 02/12/2013   | n/a        |             |
| IB/0018     | B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place                   | 29/10/2013   | n/a        |             |
| N/0017      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                             | 07/08/2013   | 18/12/2013 | PL          |
| IG/0317     | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                               | 23/07/2013   | n/a        |             |

<div style=\"page-break-after: always\"></div>

| II/0014/G   | This was an application for a group of variations.   | 25/04/2013   | n/a   |
|-------------|------------------------------------------------------|--------------|-------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | takes place A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release) A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |            |            |          |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------|
| II/0013/G | This was an application for a group of variations. B.I.a.1.e - Addition of Hospira Zagreb d.o.o, Prudnika cesta 60, 10291 Prigorje Brdoveko, Croatia, for manufacture and quality control of the active substance. B.I.a.1.f - Registration of new sites for testing of master and working cell banks. B.I.a.2.c - Changes to the manufacturing process of the active substance. B.I.a.3.c - Increase in the batch size of the active substance manufacture. B.I.a.4.a - Tightening of an in-process test specification. B.I.a.4.b - Addition of new in-process tests. B.I.a.4.z - Reclassification of in-process tests. B.I.b.1.d - Deletion of tests from the specifications for the inclusion bodies. B.I.c.1.b - A new container closure system is proposed for storage of the active substance. B.I.a.1.e - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The | 25/04/2013 | 18/12/2013 | Annex II |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| material [-] used in the biological/immunological B.I.a.1.f - Change in the starting material/reagent/intermediate Changes to quality control the AS -replacement or batch control/testing takes B.I.a.2.c - Changes in the AS - The change refers manufacture of a biological/immunological product and is not related B.I.a.3.c - Change in batch ranges) of AS or intermediate assessment of the comparability biological/immunological B.I.a.4.a - Change to in-process applied during the manufacture Tightening of in-process B.I.a.4.b - Change to in-process applied during the manufacture of a new in-process test B.I.a.4.z - Change to in-process applied during the manufacture variation B.I.b.1.d - Change in the and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.c.1.b - Change in immediate - Qualitative and/or quantitative   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| IG/0286   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 12/04/2013   | n/a        |                                  |                                                                                                                                                                                                                     |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0011   | Update of section 4.8 of the SmPC as per the reference medicinal product (Neupogen, Amgen Europe BV.) and in accordance with the Hospira global Core Safety Information. Angiopathy and information relating to pseudogout have been added and the term, \" decreased glucose\" has been amended to \"blood glucose decreased\" in-line with the reference product. A minor editorial correction was also included. The PL has also been updated accordingly. In addition, the MAH took the opportunity to update the list of local representatives in the PL. Furthermore, the PI is being brought in line with the latest QRD template version 8.2. C.I.2.b - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Change(s) require to be further substantiated by new additional data to be submitted | 13/12/2012   | 18/12/2013 | SmPC, Annex II, Labelling and PL | The MAH aligned the product information of Nivestim with the current safety information of the reference medicinal product Neupogen. No cases of pseudogout and angiopathy were retrieved from the safety database. |
| IB/0012   | B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 18/10/2012   | n/a        |                                  |                                                                                                                                                                                                                     |

<div style=\"page-break-after: always\"></div>

| IAIN/0010   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 23/07/2012   | n/a   |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
| IB/0009     | B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 18/07/2012   | n/a   |
| IAIN/0007   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 04/05/2012   | n/a   |
| IAIN/0008/G | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.e - Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the major contractual arrangements with other persons or organisations involved in the fulfilment of pharmacovigilance obligations and described in the DD C.I.9.g - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the site undertaking pharmacovigilance activities C.I.9.h - Changes to an existing pharmacovigilance | 18/04/2012   | n/a   |

<div style=\"page-break-after: always\"></div>

|         | as described in the DDPS - Other change(s) the DDPS that does not impact on the operation of pharmacovigilance system                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |            |                 | system to the   |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------|
| IB/0006 | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                                                                                                                            | 20/01/2012 | n/a        |                 |                 |
|         | This was an application for a group of variations. B.II.b.2.b.1 - Change to batch release arrangements and quality control testing of the FP - Not including batch control/testing A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                              | 23/11/2011 | 14/06/2012 | Annex II and PL | IAIN/0005/G     |
| N/0004  | Following the CHMP request, the MAH applied to update section 4 of package leaflet to include warnings with respect to reports of graft versus host disease (GvHD) and fatalities. In addition, user instructions in package leaflet have been changed to align with wording used by biological product (Neupogen) and to address concerns around the potential for loss/waste of product. Finally, the MAH took this opportunity to update the contact details for Czech, Estonian, Hungarian, Irish, Latvian, Lithuanian, Polish and Slovenian local representatives. | 25/07/2011 | 14/06/2012 | PL              |                 |

<div style=\"page-break-after: always\"></div>

|         | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                       |            |     |             |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------|
| IB/0003 | To extend the maximum out of refrigerator storage period for Nivestim from 48 hours to 7 days based on real-time data. B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                       | 19/11/2010 | n/a | SmPC and PL |
| IB/0002 | To extend the shelf-life for the 12 MU/0.2 ml and 30 MU/0.5 ml presentations from 2 years to 30 months based on real-time stability data. The shelf-life for the 48 MU/0.5 ml presentation is currently 30 months and will remain unchanged. B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) | 19/10/2010 | n/a | SmPC        |
| IA/0001 | To change the plunger rods and safety device for Nivestim 30MU and 48MU. B.II.e.6.a - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that affects the product information                                                                                                                                        | 14/07/2010 | n/a | SmPC and PL |